Fig. 1.

Patient flow chart. The merged ITT population included all patients with a baseline assessment that took at least one dose of the study medication (perindopril) and had a baseline SBP measurement. From this merged ITT, the study populations for the post hoc analyses included (i) all those who received at least one dose of combination perindopril + atorvastatin at any point during the study (merged safety population), (ii) all those patients who received combination perindopril + atorvastatin at baseline, and for whom a baseline and one or more follow-up SBP assessment were available (merged full analysis set). ITT intent-to-treat, SBP systolic blood pressure, STH Shake the Habit